Mankind Pharma's IPO listing date is expected today as experts signal a positive debut of its share price.
The company had a strong response to its IPO, with a subscription of over 200 times.
Mankind Pharma plans to use the IPO proceeds to fund its expansion plans and repay debt.
The pharmaceutical company aims to strengthen its presence in the Indian market and expand globally.
Mankind Pharma's IPO price was set at ₹ 626-628 per share, raising over ₹ 10,000 crore.
The company has a diverse portfolio of products, including medicines, personal care, and animal health.
Mankind Pharma has a presence in over 30 countries and exports its products to more than 60 countries.
The IPO is expected to provide an opportunity for investors to participate in the growth of the pharmaceutical sector.
Mankind Pharma's strong financials and leadership position in the Indian pharmaceutical market make it an attractive investment.
The listing of Mankind Pharma's IPO is expected to be closely watched by the market, with high expectations for its future performance.
Quote Of The Day
“My philosophy is: If you can’t have fun, there’s no sense in doing it.”
SWIPE UP FOR MORE SUCH CONTENT